August 9, 2021 Another class action alleges Takeda and Par have conspired to suppress competition in the generic drug market, this time for Colcrys (colchicine).
July 1, 2021 A class action alleges Takeda and Par violated antitrust law when the two struck an agreement to keep the latter’s generic version of Amitiza off the market for up to six years.
April 5, 2018 A group of pharmaceutical companies is facing a lawsuit alleging the defendants entered into an unlawful antitrust agreement that allowed them to reap significant profits from the sales of Zetia and its generic by delaying market competition.
September 6, 2017 Thirteen new cases have been filed in Pennsylvania federal court as part of a multidistrict litigation accusing numerous pharmaceutical companies of conspiring to fix the prices of generic drugs.
June 6, 2017 Seven more lawsuits have been filed this week as part of a multidistrict litigation that accuses the pharmaceutical companies of conspiring to fix generic drug prices.
June 1, 2017 Six more lawsuits have been added to a multidistrict litigation that claims various pharmaceutical companies have conspired to fix the price of generic drugs.
